Rank | Gene Set | Z-score |
---|---|---|
1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.18136721 |
2 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.11957260 |
3 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.11957260 |
4 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.04802768 |
5 | positive regulation by symbiont of host defense response (GO:0052509) | 5.03864162 |
6 | modulation by symbiont of host defense response (GO:0052031) | 5.03864162 |
7 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.03864162 |
8 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.03864162 |
9 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.03864162 |
10 | modulation by symbiont of host immune response (GO:0052553) | 5.03864162 |
11 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.55666380 |
12 | detection of bacterium (GO:0016045) | 4.48524138 |
13 | detection of other organism (GO:0098543) | 4.45137899 |
14 | neutrophil activation involved in immune response (GO:0002283) | 4.18639706 |
15 | macrophage activation involved in immune response (GO:0002281) | 4.08372534 |
16 | positive regulation of histone deacetylation (GO:0031065) | 4.08272149 |
17 | response to peptidoglycan (GO:0032494) | 4.04932310 |
18 | regulation of gamma-delta T cell activation (GO:0046643) | 4.04567969 |
19 | B cell receptor signaling pathway (GO:0050853) | 3.96362494 |
20 | positive regulation of B cell differentiation (GO:0045579) | 3.93243925 |
21 | interferon-gamma production (GO:0032609) | 3.89674264 |
22 | positive thymic T cell selection (GO:0045059) | 3.84590723 |
23 | protein localization to kinetochore (GO:0034501) | 3.80926899 |
24 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.77684751 |
25 | regulation of B cell differentiation (GO:0045577) | 3.75236392 |
26 | negative regulation of interleukin-12 production (GO:0032695) | 3.75024399 |
27 | positive regulation of protein deacetylation (GO:0090312) | 3.73858864 |
28 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.69676924 |
29 | detection of external biotic stimulus (GO:0098581) | 3.53863184 |
30 | type I interferon signaling pathway (GO:0060337) | 3.52449969 |
31 | cellular response to type I interferon (GO:0071357) | 3.52449969 |
32 | response to type I interferon (GO:0034340) | 3.50293883 |
33 | response to muramyl dipeptide (GO:0032495) | 3.49155095 |
34 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.47931876 |
35 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.44987970 |
36 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.43627002 |
37 | respiratory burst (GO:0045730) | 3.41285838 |
38 | polyketide metabolic process (GO:0030638) | 3.41237542 |
39 | doxorubicin metabolic process (GO:0044598) | 3.41237542 |
40 | daunorubicin metabolic process (GO:0044597) | 3.41237542 |
41 | cellular extravasation (GO:0045123) | 3.39768767 |
42 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.37283181 |
43 | response to host immune response (GO:0052572) | 3.37283181 |
44 | negative regulation of T cell mediated immunity (GO:0002710) | 3.36786987 |
45 | cellular response to interleukin-15 (GO:0071350) | 3.35340517 |
46 | germinal center formation (GO:0002467) | 3.33536342 |
47 | natural killer cell differentiation (GO:0001779) | 3.32889714 |
48 | regulation of T cell tolerance induction (GO:0002664) | 3.29749987 |
49 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.27131627 |
50 | negative regulation of cell killing (GO:0031342) | 3.27131627 |
51 | regulation of mast cell degranulation (GO:0043304) | 3.25231912 |
52 | thymic T cell selection (GO:0045061) | 3.21204441 |
53 | negative thymic T cell selection (GO:0045060) | 3.20853813 |
54 | immunoglobulin mediated immune response (GO:0016064) | 3.20538897 |
55 | response to host (GO:0075136) | 3.20227794 |
56 | response to host defenses (GO:0052200) | 3.20227794 |
57 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.20227794 |
58 | defense response to protozoan (GO:0042832) | 3.18196540 |
59 | negative T cell selection (GO:0043383) | 3.17384402 |
60 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.13154387 |
61 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.13133416 |
62 | myeloid cell activation involved in immune response (GO:0002275) | 3.11302509 |
63 | neutrophil activation (GO:0042119) | 3.11127678 |
64 | detection of biotic stimulus (GO:0009595) | 3.08740230 |
65 | B cell homeostasis (GO:0001782) | 3.04931054 |
66 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.04825051 |
67 | protein localization to chromosome, centromeric region (GO:0071459) | 3.03606210 |
68 | heterochromatin organization (GO:0070828) | 3.03097784 |
69 | regulation of tolerance induction (GO:0002643) | 3.00788652 |
70 | DNA unwinding involved in DNA replication (GO:0006268) | 3.00644559 |
71 | T cell selection (GO:0045058) | 3.00411373 |
72 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.99215782 |
73 | regulation of leukocyte degranulation (GO:0043300) | 2.99113851 |
74 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.98605984 |
75 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.98605984 |
76 | mRNA stabilization (GO:0048255) | 2.98298346 |
77 | RNA stabilization (GO:0043489) | 2.98298346 |
78 | response to protozoan (GO:0001562) | 2.95715510 |
79 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.93775487 |
80 | regulation of antigen processing and presentation (GO:0002577) | 2.93486978 |
81 | granulocyte activation (GO:0036230) | 2.90514103 |
82 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.89814658 |
83 | detection of molecule of bacterial origin (GO:0032490) | 2.87032381 |
84 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.86865387 |
85 | lymphocyte homeostasis (GO:0002260) | 2.86007929 |
86 | myeloid dendritic cell differentiation (GO:0043011) | 2.84697243 |
87 | negative regulation of innate immune response (GO:0045824) | 2.84600492 |
88 | myeloid dendritic cell activation (GO:0001773) | 2.84458861 |
89 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.83625992 |
90 | maternal placenta development (GO:0001893) | 2.83108740 |
91 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.82505864 |
92 | positive T cell selection (GO:0043368) | 2.81907155 |
93 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.80989897 |
94 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.80936444 |
95 | pre-miRNA processing (GO:0031054) | 2.80054167 |
96 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.78616155 |
97 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.78068298 |
98 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.77932497 |
99 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.75460710 |
100 | hepatocyte apoptotic process (GO:0097284) | 2.74526946 |
101 | response to interleukin-15 (GO:0070672) | 2.73690452 |
102 | positive regulation of mast cell activation (GO:0033005) | 2.72890000 |
103 | megakaryocyte development (GO:0035855) | 2.72718676 |
104 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.72034009 |
105 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.71739721 |
106 | positive regulation of interferon-alpha production (GO:0032727) | 2.71677726 |
107 | B cell mediated immunity (GO:0019724) | 2.70359920 |
108 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.70225943 |
109 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.69768189 |
110 | leukocyte aggregation (GO:0070486) | 2.67992366 |
111 | maintenance of protein location in nucleus (GO:0051457) | 2.67832952 |
112 | chromatin assembly (GO:0031497) | 2.67052699 |
113 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.66748680 |
114 | positive regulation of isotype switching (GO:0045830) | 2.66336506 |
115 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.65583063 |
116 | regulation of telomere maintenance via telomerase (GO:0032210) | 2.65376979 |
117 | ribosomal small subunit biogenesis (GO:0042274) | 2.61591334 |
118 | cytidine deamination (GO:0009972) | 2.61236389 |
119 | cytidine metabolic process (GO:0046087) | 2.61236389 |
120 | cytidine catabolic process (GO:0006216) | 2.61236389 |
121 | mitotic sister chromatid segregation (GO:0000070) | 2.61164760 |
122 | viral transcription (GO:0019083) | 2.61047122 |
123 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.60075064 |
124 | natural killer cell activation (GO:0030101) | 2.58682339 |
125 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.58418218 |
126 | tolerance induction (GO:0002507) | 2.58229261 |
127 | nuclear pore complex assembly (GO:0051292) | 2.58149943 |
128 | T cell migration (GO:0072678) | 2.57027957 |
129 | * antigen receptor-mediated signaling pathway (GO:0050851) | 2.56161212 |
130 | NIK/NF-kappaB signaling (GO:0038061) | 2.55347826 |
131 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.54639185 |
132 | positive regulation of interleukin-2 production (GO:0032743) | 2.52033628 |
133 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.51568851 |
134 | ribosomal small subunit assembly (GO:0000028) | 2.51345832 |
135 | T cell homeostasis (GO:0043029) | 2.50767425 |
136 | sister chromatid segregation (GO:0000819) | 2.49443288 |
137 | histone H4-K12 acetylation (GO:0043983) | 2.49405068 |
138 | response to laminar fluid shear stress (GO:0034616) | 2.48783247 |
139 | regulation of MHC class I biosynthetic process (GO:0045343) | 2.47883521 |
140 | adaptation of signaling pathway (GO:0023058) | 2.46524856 |
141 | positive regulation of gene expression, epigenetic (GO:0045815) | 2.45248687 |
142 | cellular response to interleukin-4 (GO:0071353) | 2.45204093 |
143 | negative regulation of telomerase activity (GO:0051974) | 2.44277865 |
144 | DNA duplex unwinding (GO:0032508) | 2.43373785 |
145 | regulation of erythrocyte differentiation (GO:0045646) | 2.43288238 |
146 | rRNA transcription (GO:0009303) | 2.43043382 |
147 | histone H4-K5 acetylation (GO:0043981) | 2.41067467 |
148 | histone H4-K8 acetylation (GO:0043982) | 2.41067467 |
149 | translational termination (GO:0006415) | 2.40390685 |
150 | DNA geometric change (GO:0032392) | 2.39681918 |
151 | negative regulation of cell cycle G2/M phase transition (GO:1902750) | 2.39544958 |
152 | cellular response to zinc ion (GO:0071294) | 2.39093911 |
153 | pentose-phosphate shunt (GO:0006098) | 2.38775684 |
154 | regulation of translation in response to stress (GO:0043555) | 2.38681643 |
155 | negative regulation of histone methylation (GO:0031061) | 2.37255473 |
156 | regulation of response to interferon-gamma (GO:0060330) | 2.35908919 |
157 | establishment of endothelial barrier (GO:0061028) | 2.35141650 |
158 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 2.34944205 |
159 | regulation of necroptotic process (GO:0060544) | 2.34937357 |
160 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.34876635 |
161 | histone H4-K16 acetylation (GO:0043984) | 2.34771869 |
162 | endothelial tube morphogenesis (GO:0061154) | 2.34320686 |
163 | morphogenesis of an endothelium (GO:0003159) | 2.34320686 |
Rank | Gene Set | Z-score |
---|---|---|
1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.43846773 |
2 | * MYC_22102868_ChIP-Seq_BL_Human | 3.81589624 |
3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.32225214 |
4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.08014557 |
5 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.93582732 |
6 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.71537130 |
7 | * VDR_21846776_ChIP-Seq_THP-1_Human | 2.69802992 |
8 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.54171103 |
9 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.32045548 |
10 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.30812351 |
11 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.27252577 |
12 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.25507155 |
13 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.22804126 |
14 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 2.18945317 |
15 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.17908760 |
16 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.16940034 |
17 | MAF_26560356_Chip-Seq_TH1_Human | 2.15673637 |
18 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.99108685 |
19 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.99090388 |
20 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.95191962 |
21 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.91999389 |
22 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.91929046 |
23 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.89050064 |
24 | * MYB_26560356_Chip-Seq_TH2_Human | 1.86148086 |
25 | * MYB_26560356_Chip-Seq_TH1_Human | 1.84925434 |
26 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.77601952 |
27 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.75749653 |
28 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.75654637 |
29 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.73460939 |
30 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.72364588 |
31 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.70587545 |
32 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.70390320 |
33 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.69270327 |
34 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.69091641 |
35 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.67855454 |
36 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.65393427 |
37 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.64664685 |
38 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.64610723 |
39 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.64489625 |
40 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.63495596 |
41 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.61319560 |
42 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.60151171 |
43 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.58479973 |
44 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.56177845 |
45 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.54832374 |
46 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.53439012 |
47 | * MAF_26560356_Chip-Seq_TH2_Human | 1.49436604 |
48 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.48490948 |
49 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.48298537 |
50 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.47415669 |
51 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.47415669 |
52 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.47415669 |
53 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.46483230 |
54 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.45178920 |
55 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.44948462 |
56 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.44839005 |
57 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.44444747 |
58 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.42930943 |
59 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.40937667 |
60 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.40529728 |
61 | * RUNX_20019798_ChIP-Seq_JUKART_Human | 1.40257453 |
62 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.34846378 |
63 | SPI1_23127762_ChIP-Seq_K562_Human | 1.32849296 |
64 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.32191907 |
65 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.30532229 |
66 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.28839093 |
67 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.25351282 |
68 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.25236797 |
69 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.25169250 |
70 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.24769590 |
71 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.22222140 |
72 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.21294077 |
73 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.21229182 |
74 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.19631899 |
75 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.17654510 |
76 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.17164070 |
77 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.17044281 |
78 | P68_20966046_ChIP-Seq_HELA_Human | 1.16444718 |
79 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.12894483 |
80 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.11183881 |
81 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.11176398 |
82 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.10900809 |
83 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.10689337 |
84 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.06692611 |
85 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.03637069 |
86 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.03509668 |
87 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.02245252 |
88 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.01567954 |
89 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.01563148 |
90 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.01419631 |
91 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.01370898 |
92 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.01049350 |
93 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.00402021 |
94 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.99918221 |
95 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 0.99124761 |
96 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.98427251 |
97 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.98043719 |
98 | KDM2B_26808549_Chip-Seq_K562_Human | 0.96732739 |
99 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.95759007 |
100 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.95673454 |
101 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.95334616 |
102 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.94864136 |
103 | GATA1_19941826_ChIP-Seq_K562_Human | 0.94851478 |
104 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.94724232 |
105 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.94623284 |
106 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 0.94499497 |
107 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.94133689 |
108 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.93422304 |
109 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.92106029 |
110 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.91920985 |
111 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.91830077 |
112 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.90995238 |
113 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.90876054 |
114 | * CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.89222803 |
115 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.88861295 |
116 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.88501909 |
117 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.88276986 |
118 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.87919188 |
119 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.87804742 |
120 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.87798354 |
121 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.87700002 |
122 | * KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.87075312 |
123 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.86621194 |
124 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.85912136 |
125 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.85658094 |
126 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.85122606 |
127 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.84939382 |
128 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.84343390 |
129 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.84212732 |
130 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.84208432 |
131 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.83929326 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0001835_abnormal_antigen_presentation | 3.34403947 |
2 | MP0001800_abnormal_humoral_immune | 3.00757026 |
3 | MP0000685_abnormal_immune_system | 2.93215456 |
4 | MP0002396_abnormal_hematopoietic_system | 2.88343459 |
5 | MP0001790_abnormal_immune_system | 2.76715926 |
6 | MP0005387_immune_system_phenotype | 2.76715926 |
7 | MP0003303_peritoneal_inflammation | 2.59142475 |
8 | MP0003763_abnormal_thymus_physiology | 2.50285316 |
9 | MP0002452_abnormal_antigen_presenting | 2.40843674 |
10 | MP0005671_abnormal_response_to | 2.39339428 |
11 | MP0003436_decreased_susceptibility_to | 2.37812364 |
12 | * MP0002398_abnormal_bone_marrow | 2.36231484 |
13 | MP0010352_gastrointestinal_tract_polyps | 2.32294433 |
14 | MP0005000_abnormal_immune_tolerance | 2.27299929 |
15 | MP0002723_abnormal_immune_serum | 2.21717855 |
16 | * MP0002420_abnormal_adaptive_immunity | 2.21566634 |
17 | * MP0001819_abnormal_immune_cell | 2.18428867 |
18 | MP0000689_abnormal_spleen_morphology | 2.15724136 |
19 | MP0006082_CNS_inflammation | 2.08300187 |
20 | * MP0000716_abnormal_immune_system | 2.05364048 |
21 | MP0003300_gastrointestinal_ulcer | 2.05061178 |
22 | * MP0002722_abnormal_immune_system | 2.02004106 |
23 | MP0005451_abnormal_body_composition | 1.98619209 |
24 | MP0002405_respiratory_system_inflammati | 1.95574440 |
25 | MP0008057_abnormal_DNA_replication | 1.94027528 |
26 | MP0008260_abnormal_autophagy | 1.91342974 |
27 | * MP0005025_abnormal_response_to | 1.89827182 |
28 | MP0004808_abnormal_hematopoietic_stem | 1.89744909 |
29 | MP0009333_abnormal_splenocyte_physiolog | 1.88138643 |
30 | MP0003705_abnormal_hypodermis_morpholog | 1.87186706 |
31 | * MP0002429_abnormal_blood_cell | 1.83843197 |
32 | MP0000703_abnormal_thymus_morphology | 1.78814207 |
33 | MP0005075_abnormal_melanosome_morpholog | 1.78495869 |
34 | MP0009785_altered_susceptibility_to | 1.73230293 |
35 | MP0010155_abnormal_intestine_physiology | 1.71012135 |
36 | MP0002254_reproductive_system_inflammat | 1.70952461 |
37 | MP0009278_abnormal_bone_marrow | 1.69350946 |
38 | MP0000490_abnormal_crypts_of | 1.64805299 |
39 | MP0005464_abnormal_platelet_physiology | 1.63896510 |
40 | MP0005058_abnormal_lysosome_morphology | 1.61993814 |
41 | MP0001873_stomach_inflammation | 1.61301604 |
42 | MP0004957_abnormal_blastocyst_morpholog | 1.60918239 |
43 | MP0002419_abnormal_innate_immunity | 1.55952968 |
44 | MP0002166_altered_tumor_susceptibility | 1.55120865 |
45 | MP0004947_skin_inflammation | 1.51417132 |
46 | MP0003077_abnormal_cell_cycle | 1.49464808 |
47 | MP0004381_abnormal_hair_follicle | 1.49391470 |
48 | MP0005397_hematopoietic_system_phenotyp | 1.49073894 |
49 | MP0001545_abnormal_hematopoietic_system | 1.49073894 |
50 | MP0004264_abnormal_extraembryonic_tissu | 1.45897522 |
51 | MP0000465_gastrointestinal_hemorrhage | 1.35805305 |
52 | * MP0001845_abnormal_inflammatory_respons | 1.35517789 |
53 | MP0001853_heart_inflammation | 1.33160826 |
54 | MP0002019_abnormal_tumor_incidence | 1.30639589 |
55 | MP0008961_abnormal_basal_metabolism | 1.30570169 |
56 | MP0010094_abnormal_chromosome_stability | 1.26602441 |
57 | MP0002148_abnormal_hypersensitivity_rea | 1.26553744 |
58 | MP0003111_abnormal_nucleus_morphology | 1.23428420 |
59 | MP0000858_altered_metastatic_potential | 1.22739671 |
60 | MP0003191_abnormal_cellular_cholesterol | 1.21465044 |
61 | MP0003693_abnormal_embryo_hatching | 1.20881298 |
62 | MP0004510_myositis | 1.20448549 |
63 | MP0001851_eye_inflammation | 1.18719463 |
64 | MP0002998_abnormal_bone_remodeling | 1.16525971 |
65 | MP0000350_abnormal_cell_proliferation | 1.15746609 |
66 | MP0003866_abnormal_defecation | 1.15114073 |
67 | MP0003828_pulmonary_edema | 1.13535999 |
68 | MP0005076_abnormal_cell_differentiation | 1.12746931 |
69 | MP0005023_abnormal_wound_healing | 1.11240715 |
70 | MP0003448_altered_tumor_morphology | 1.10011822 |
71 | MP0002006_tumorigenesis | 1.08369239 |
72 | MP0003183_abnormal_peptide_metabolism | 1.07700354 |
73 | MP0009840_abnormal_foam_cell | 1.06061393 |
74 | MP0003566_abnormal_cell_adhesion | 1.02812463 |
75 | MP0010307_abnormal_tumor_latency | 1.02457192 |
76 | MP0005310_abnormal_salivary_gland | 1.01451711 |
77 | MP0008469_abnormal_protein_level | 1.00591735 |
78 | MP0002132_abnormal_respiratory_system | 0.99351213 |
79 | MP0002138_abnormal_hepatobiliary_system | 0.97290260 |
80 | MP0001663_abnormal_digestive_system | 0.95492413 |
81 | MP0000609_abnormal_liver_physiology | 0.93306859 |
82 | * MP0000313_abnormal_cell_death | 0.92185740 |
83 | MP0008007_abnormal_cellular_replicative | 0.91419343 |
84 | MP0003172_abnormal_lysosome_physiology | 0.91340487 |
85 | MP0003011_delayed_dark_adaptation | 0.91292870 |
86 | MP0002933_joint_inflammation | 0.91027715 |
87 | MP0009764_decreased_sensitivity_to | 0.90396900 |
88 | MP0001849_ear_inflammation | 0.90149497 |
89 | * MP0002088_abnormal_embryonic_growth/wei | 0.88972071 |
90 | * MP0003984_embryonic_growth_retardation | 0.88727283 |
91 | * MP0005380_embryogenesis_phenotype | 0.87394670 |
92 | * MP0001672_abnormal_embryogenesis/_devel | 0.87394670 |
93 | * MP0002086_abnormal_extraembryonic_tissu | 0.85467820 |
94 | MP0003075_altered_response_to | 0.85394313 |
95 | MP0001533_abnormal_skeleton_physiology | 0.85286711 |
96 | MP0005166_decreased_susceptibility_to | 0.85244542 |
97 | MP0000598_abnormal_liver_morphology | 0.82836261 |
98 | MP0004185_abnormal_adipocyte_glucose | 0.79099968 |
99 | MP0004883_abnormal_blood_vessel | 0.77755897 |
100 | MP0000477_abnormal_intestine_morphology | 0.76164460 |
101 | * MP0001730_embryonic_growth_arrest | 0.74783670 |
102 | MP0005390_skeleton_phenotype | 0.74242548 |
103 | MP0002970_abnormal_white_adipose | 0.73869889 |
104 | MP0002009_preneoplasia | 0.73638576 |
105 | MP0009763_increased_sensitivity_to | 0.72969283 |
106 | MP0005257_abnormal_intraocular_pressure | 0.71546963 |
107 | MP0002277_abnormal_respiratory_mucosa | 0.71213841 |
108 | MP0000604_amyloidosis | 0.71205099 |
109 | MP0000343_altered_response_to | 0.69640446 |
110 | MP0002080_prenatal_lethality | 0.68305278 |
111 | MP0000015_abnormal_ear_pigmentation | 0.67463553 |
112 | MP0003724_increased_susceptibility_to | 0.66735434 |
113 | MP0004197_abnormal_fetal_growth/weight/ | 0.66731999 |
114 | MP0001348_abnormal_lacrimal_gland | 0.65610092 |
115 | MP0008874_decreased_physiological_sensi | 0.63692049 |
116 | MP0008770_decreased_survivor_rate | 0.62501153 |
117 | MP0003795_abnormal_bone_structure | 0.62198788 |
118 | MP0003091_abnormal_cell_migration | 0.62130920 |
119 | MP0003453_abnormal_keratinocyte_physiol | 0.61556796 |
120 | MP0005174_abnormal_tail_pigmentation | 0.61083905 |
121 | MP0005381_digestive/alimentary_phenotyp | 0.61040644 |
122 | MP0003045_fibrosis | 0.60296375 |
123 | MP0002877_abnormal_melanocyte_morpholog | 0.59246676 |
124 | MP0008873_increased_physiological_sensi | 0.59192751 |
125 | MP0000249_abnormal_blood_vessel | 0.58722344 |
126 | MP0003690_abnormal_glial_cell | 0.56913790 |
127 | MP0004858_abnormal_nervous_system | 0.54046690 |
128 | MP0009765_abnormal_xenobiotic_induced | 0.50301856 |
129 | MP0005621_abnormal_cell_physiology | 0.50223646 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Abnormality of macrophages (HP:0004311) | 4.73593727 |
2 | Cellulitis (HP:0100658) | 4.07816527 |
3 | Agammaglobulinemia (HP:0004432) | 3.99818978 |
4 | Recurrent viral infections (HP:0004429) | 3.95989216 |
5 | Orchitis (HP:0100796) | 3.85747223 |
6 | Recurrent bronchitis (HP:0002837) | 3.73929699 |
7 | Nasal polyposis (HP:0100582) | 3.69107441 |
8 | IgM deficiency (HP:0002850) | 3.67278572 |
9 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.64491584 |
10 | Panhypogammaglobulinemia (HP:0003139) | 3.59396271 |
11 | Optic neuritis (HP:0100653) | 3.57708552 |
12 | Retrobulbar optic neuritis (HP:0100654) | 3.57708552 |
13 | Gastrointestinal infarctions (HP:0005244) | 3.54072344 |
14 | Colitis (HP:0002583) | 3.44168739 |
15 | Gastrointestinal inflammation (HP:0004386) | 3.41229608 |
16 | Inflammation of the large intestine (HP:0002037) | 3.38811874 |
17 | Recurrent fungal infections (HP:0002841) | 3.33579124 |
18 | Multiple enchondromatosis (HP:0005701) | 3.28859368 |
19 | Abnormality of the nasal mucosa (HP:0000433) | 3.28449619 |
20 | Stomatitis (HP:0010280) | 3.26788508 |
21 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.23793129 |
22 | Verrucae (HP:0200043) | 3.20353278 |
23 | Papilloma (HP:0012740) | 3.20353278 |
24 | Combined immunodeficiency (HP:0005387) | 3.10522083 |
25 | Urticaria (HP:0001025) | 3.08790278 |
26 | T lymphocytopenia (HP:0005403) | 3.06977654 |
27 | Abnormality of T cells (HP:0002843) | 3.03236760 |
28 | Gingivitis (HP:0000230) | 3.02338314 |
29 | Eczematoid dermatitis (HP:0000976) | 3.00548748 |
30 | Chronic otitis media (HP:0000389) | 2.94755432 |
31 | Abnormality of T cell physiology (HP:0011840) | 2.91843608 |
32 | Abnormality of T cell number (HP:0011839) | 2.90411390 |
33 | Meningitis (HP:0001287) | 2.90361531 |
34 | Hypochromic anemia (HP:0001931) | 2.89444674 |
35 | Hypochromic microcytic anemia (HP:0004840) | 2.79912528 |
36 | Recurrent abscess formation (HP:0002722) | 2.78320152 |
37 | Spontaneous hematomas (HP:0007420) | 2.74397620 |
38 | Keratoconjunctivitis sicca (HP:0001097) | 2.62146688 |
39 | Petechiae (HP:0000967) | 2.58290921 |
40 | Increased IgM level (HP:0003496) | 2.57813802 |
41 | Abnormality of the fingertips (HP:0001211) | 2.57003620 |
42 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.55702019 |
43 | Recurrent cutaneous fungal infections (HP:0011370) | 2.55702019 |
44 | Pustule (HP:0200039) | 2.54136894 |
45 | Recurrent bacterial skin infections (HP:0005406) | 2.53167167 |
46 | Myositis (HP:0100614) | 2.50343426 |
47 | Thrombocytosis (HP:0001894) | 2.47502874 |
48 | Gastrointestinal stroma tumor (HP:0100723) | 2.46952241 |
49 | Hemoptysis (HP:0002105) | 2.46225944 |
50 | Lymphopenia (HP:0001888) | 2.43410395 |
51 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.41186507 |
52 | Abnormality of B cell number (HP:0010975) | 2.41147135 |
53 | B lymphocytopenia (HP:0010976) | 2.41147135 |
54 | Autoimmune thrombocytopenia (HP:0001973) | 2.40260384 |
55 | Vasculitis (HP:0002633) | 2.39329699 |
56 | Emphysema (HP:0002097) | 2.38552405 |
57 | Purpura (HP:0000979) | 2.38135038 |
58 | Prolonged bleeding time (HP:0003010) | 2.33192904 |
59 | Recurrent sinusitis (HP:0011108) | 2.32934736 |
60 | Keratoconjunctivitis (HP:0001096) | 2.32860049 |
61 | Bilateral microphthalmos (HP:0007633) | 2.32730388 |
62 | Chest pain (HP:0100749) | 2.31038931 |
63 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.27490742 |
64 | Arterial thrombosis (HP:0004420) | 2.25146452 |
65 | Osteomyelitis (HP:0002754) | 2.23179757 |
66 | Pulmonary embolism (HP:0002204) | 2.22109993 |
67 | Hypergammaglobulinemia (HP:0010702) | 2.21696126 |
68 | Cheilitis (HP:0100825) | 2.16271647 |
69 | Recurrent lower respiratory tract infections (HP:0002783) | 2.16081057 |
70 | Recurrent skin infections (HP:0001581) | 2.15954233 |
71 | Increased IgE level (HP:0003212) | 2.14070808 |
72 | Increased cerebral lipofuscin (HP:0011813) | 2.13141215 |
73 | Hypertensive crisis (HP:0100735) | 2.13109433 |
74 | Gingival bleeding (HP:0000225) | 2.12890000 |
75 | Recurrent pneumonia (HP:0006532) | 2.11663262 |
76 | Impaired platelet aggregation (HP:0003540) | 2.10953620 |
77 | Abnormal platelet function (HP:0011869) | 2.10953620 |
78 | Ulnar bowing (HP:0003031) | 2.09072966 |
79 | Slow saccadic eye movements (HP:0000514) | 2.08087417 |
80 | Abnormal platelet volume (HP:0011876) | 2.07341567 |
81 | Ependymoma (HP:0002888) | 2.07009091 |
82 | IgA deficiency (HP:0002720) | 2.04933139 |
83 | Abnormality of the peritoneum (HP:0002585) | 2.04741010 |
84 | Rhabdomyosarcoma (HP:0002859) | 2.04356723 |
85 | Epistaxis (HP:0000421) | 2.02886243 |
86 | Autoimmune hemolytic anemia (HP:0001890) | 2.01859333 |
87 | Restrictive lung disease (HP:0002091) | 2.00495968 |
88 | Neoplasm of striated muscle (HP:0009728) | 1.99604858 |
89 | Thyroiditis (HP:0100646) | 1.99332145 |
90 | Abnormality of the pleura (HP:0002103) | 1.98540383 |
91 | Premature loss of primary teeth (HP:0006323) | 1.98246720 |
92 | Mediastinal lymphadenopathy (HP:0100721) | 1.97724078 |
93 | Leukocytosis (HP:0001974) | 1.97616901 |
94 | Viral hepatitis (HP:0006562) | 1.97271956 |
95 | Basal cell carcinoma (HP:0002671) | 1.95577020 |
96 | Increased serum ferritin (HP:0003281) | 1.95249738 |
97 | Hepatosplenomegaly (HP:0001433) | 1.95178379 |
98 | Anorexia (HP:0002039) | 1.95117642 |
99 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.94049897 |
100 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.94049897 |
101 | Abnormality of glycolipid metabolism (HP:0010969) | 1.94049897 |
102 | Bronchitis (HP:0012387) | 1.93305619 |
103 | Lymphoma (HP:0002665) | 1.93173487 |
104 | Eosinophilia (HP:0001880) | 1.92892127 |
105 | Glomerulopathy (HP:0100820) | 1.92286929 |
106 | Episodic fever (HP:0001954) | 1.92011581 |
107 | Increased density of long bones (HP:0006392) | 1.91380246 |
108 | Loss of speech (HP:0002371) | 1.90357124 |
109 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.88444171 |
110 | Dysostosis multiplex (HP:0000943) | 1.88002695 |
111 | Arthralgia (HP:0002829) | 1.87510915 |
112 | Chronic diarrhea (HP:0002028) | 1.87419452 |
113 | Interstitial pulmonary disease (HP:0006530) | 1.86444276 |
114 | Skin tags (HP:0010609) | 1.85915464 |
115 | Encephalitis (HP:0002383) | 1.85721071 |
116 | Chronic sinusitis (HP:0011109) | 1.85584911 |
117 | Granulocytopenia (HP:0001913) | 1.85022009 |
118 | Fatigue (HP:0012378) | 1.83911402 |
119 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.83051638 |
120 | Periodontitis (HP:0000704) | 1.82703905 |
121 | Severe combined immunodeficiency (HP:0004430) | 1.82632240 |
122 | Microcytic anemia (HP:0001935) | 1.79315461 |
123 | IgG deficiency (HP:0004315) | 1.79248107 |
124 | Chronic obstructive pulmonary disease (HP:0006510) | 1.77505790 |
125 | Obstructive lung disease (HP:0006536) | 1.77505790 |
126 | Abnormality of the intervertebral disk (HP:0005108) | 1.77401568 |
127 | Skin ulcer (HP:0200042) | 1.77143216 |
128 | Abnormality of the lower motor neuron (HP:0002366) | 1.77004281 |
129 | Rib fusion (HP:0000902) | 1.75882689 |
130 | Preauricular skin tag (HP:0000384) | 1.75860625 |
131 | Sepsis (HP:0100806) | 1.72990426 |
132 | Abnormal cartilage morphology (HP:0002763) | 1.72361992 |
133 | Skin rash (HP:0000988) | 1.72204404 |
134 | Pulmonary infiltrates (HP:0002113) | 1.70685958 |
135 | Myocardial infarction (HP:0001658) | 1.70189587 |
136 | Hepatoblastoma (HP:0002884) | 1.70092698 |
137 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.67495390 |
138 | Villous atrophy (HP:0011473) | 1.67495390 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAP4K1 | 4.54458197 |
2 | CDK12 | 4.42658731 |
3 | ERN1 | 4.06875838 |
4 | GRK6 | 3.81059074 |
5 | MAP3K10 | 3.59851403 |
6 | PRPF4B | 3.57428911 |
7 | EEF2K | 2.77871747 |
8 | STK10 | 2.77020816 |
9 | CSF1R | 2.67682386 |
10 | TRIB3 | 2.54244219 |
11 | SMG1 | 2.35689703 |
12 | TGFBR2 | 2.16651435 |
13 | PKN2 | 2.16195089 |
14 | BLK | 2.02923225 |
15 | MAP3K13 | 1.92811760 |
16 | TYK2 | 1.72767046 |
17 | ZAP70 | 1.71370554 |
18 | KIT | 1.57033804 |
19 | BTK | 1.52780079 |
20 | SIK3 | 1.51255205 |
21 | JAK3 | 1.48917051 |
22 | LRRK2 | 1.45687089 |
23 | SYK | 1.42973597 |
24 | MATK | 1.40207384 |
25 | FGFR3 | 1.34307118 |
26 | TBK1 | 1.29745881 |
27 | ITK | 1.28877571 |
28 | IRAK3 | 1.21357333 |
29 | TAOK2 | 1.17699853 |
30 | FGR | 1.16816294 |
31 | MAP2K3 | 1.15517409 |
32 | HCK | 1.12427561 |
33 | FGFR4 | 1.12393713 |
34 | GRK5 | 1.11979636 |
35 | NEK2 | 1.11486320 |
36 | CDK4 | 1.11081831 |
37 | SIK2 | 1.09359867 |
38 | MAP3K1 | 1.07179236 |
39 | ICK | 1.05787949 |
40 | PIM1 | 1.05387982 |
41 | TXK | 1.05141984 |
42 | ALK | 1.03299478 |
43 | HIPK2 | 1.02463472 |
44 | IKBKB | 1.01915313 |
45 | KSR2 | 1.00883379 |
46 | LCK | 0.95861023 |
47 | MAPK7 | 0.95806999 |
48 | TESK2 | 0.94149499 |
49 | IKBKE | 0.90762270 |
50 | CDC42BPA | 0.88924010 |
51 | JAK1 | 0.88820506 |
52 | NME2 | 0.85024967 |
53 | GRK1 | 0.84585070 |
54 | CLK1 | 0.83480445 |
55 | RPS6KB2 | 0.83396907 |
56 | MAP3K7 | 0.82935136 |
57 | PAK4 | 0.82399288 |
58 | FLT3 | 0.81710367 |
59 | PDPK1 | 0.80823902 |
60 | MAP3K14 | 0.80661807 |
61 | PTK6 | 0.79445864 |
62 | RIPK1 | 0.77119315 |
63 | LYN | 0.76620674 |
64 | TAOK3 | 0.76300760 |
65 | RPS6KA4 | 0.75731209 |
66 | SIK1 | 0.75314264 |
67 | CDK7 | 0.75198396 |
68 | IRAK2 | 0.72122942 |
69 | TYRO3 | 0.70454571 |
70 | CDC7 | 0.67236821 |
71 | PRKD2 | 0.65910735 |
72 | MAP3K8 | 0.65353647 |
73 | * CSK | 0.64827446 |
74 | STK4 | 0.64207711 |
75 | JAK2 | 0.63678094 |
76 | PRKG2 | 0.63450676 |
77 | TAOK1 | 0.62730606 |
78 | ADRBK2 | 0.62554306 |
79 | TNK2 | 0.62127505 |
80 | EPHB1 | 0.61560030 |
81 | MARK2 | 0.61213723 |
82 | PIM2 | 0.60824611 |
83 | SCYL2 | 0.60801430 |
84 | CHUK | 0.60396901 |
85 | TEC | 0.60264485 |
86 | CDK6 | 0.60131562 |
87 | CAMKK1 | 0.59523501 |
88 | MAP2K2 | 0.57695388 |
89 | IRAK4 | 0.57238534 |
90 | RPS6KC1 | 0.56936976 |
91 | RPS6KL1 | 0.56936976 |
92 | MARK3 | 0.55812607 |
93 | TTK | 0.55386205 |
94 | MAPK4 | 0.55175422 |
95 | YES1 | 0.52605927 |
96 | PASK | 0.52237959 |
97 | MOS | 0.51940166 |
98 | MTOR | 0.51627648 |
99 | PRKCH | 0.50665510 |
100 | IRAK1 | 0.50112294 |
101 | FES | 0.49827403 |
102 | MAP3K11 | 0.49473748 |
103 | BMX | 0.49429321 |
104 | BMPR2 | 0.49042275 |
105 | FYN | 0.48253555 |
106 | NLK | 0.47264259 |
107 | GRK7 | 0.46765064 |
108 | MAPK11 | 0.46395082 |
109 | MAPK12 | 0.46244688 |
110 | ARAF | 0.42574268 |
111 | CDK19 | 0.42467882 |
112 | CHEK1 | 0.41489571 |
113 | CAMK4 | 0.41314735 |
114 | MAPKAPK2 | 0.40793186 |
115 | RIPK4 | 0.39507876 |
116 | KDR | 0.39223860 |
117 | RET | 0.38214871 |
118 | RPS6KA2 | 0.38141685 |
119 | MAP3K3 | 0.37097664 |
120 | PDK1 | 0.34871455 |
121 | TTN | 0.34779728 |
122 | EGFR | 0.33191272 |
123 | PRKCQ | 0.32336276 |
124 | DYRK1B | 0.31844061 |
125 | TGFBR1 | 0.31791422 |
126 | SGK3 | 0.31208065 |
127 | RPS6KA6 | 0.31172746 |
128 | STK3 | 0.30246011 |
129 | RAF1 | 0.29002274 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.95591124 |
2 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 3.11933813 |
3 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.64972822 |
4 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.62007102 |
5 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.16474540 |
6 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.00739246 |
7 | Leishmaniasis_Homo sapiens_hsa05140 | 1.98559496 |
8 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.96555222 |
9 | DNA replication_Homo sapiens_hsa03030 | 1.92685075 |
10 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.92660230 |
11 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.86913159 |
12 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.86570716 |
13 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.84168503 |
14 | Asthma_Homo sapiens_hsa05310 | 1.80643431 |
15 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.78811417 |
16 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.76619038 |
17 | Measles_Homo sapiens_hsa05162 | 1.74120766 |
18 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.70320865 |
19 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.69161287 |
20 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.58575653 |
21 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.55321154 |
22 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.54292064 |
23 | Base excision repair_Homo sapiens_hsa03410 | 1.51669031 |
24 | Ribosome_Homo sapiens_hsa03010 | 1.50373454 |
25 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.43969279 |
26 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.38927588 |
27 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.35430564 |
28 | Apoptosis_Homo sapiens_hsa04210 | 1.33328553 |
29 | Mismatch repair_Homo sapiens_hsa03430 | 1.31375876 |
30 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.28512193 |
31 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.27634276 |
32 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.25910527 |
33 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.25504091 |
34 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.23336832 |
35 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.21171009 |
36 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.20845160 |
37 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.20519173 |
38 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.19851142 |
39 | Hepatitis B_Homo sapiens_hsa05161 | 1.18156663 |
40 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.15357831 |
41 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.14091605 |
42 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.12937013 |
43 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.11932485 |
44 | Influenza A_Homo sapiens_hsa05164 | 1.09103658 |
45 | Shigellosis_Homo sapiens_hsa05131 | 1.05965650 |
46 | Phagosome_Homo sapiens_hsa04145 | 1.02196200 |
47 | HTLV-I infection_Homo sapiens_hsa05166 | 1.01967999 |
48 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.01152603 |
49 | Other glycan degradation_Homo sapiens_hsa00511 | 0.99790207 |
50 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.99211157 |
51 | Platelet activation_Homo sapiens_hsa04611 | 0.98965283 |
52 | Tuberculosis_Homo sapiens_hsa05152 | 0.98951412 |
53 | Viral myocarditis_Homo sapiens_hsa05416 | 0.98860162 |
54 | Cell cycle_Homo sapiens_hsa04110 | 0.96490003 |
55 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.95800536 |
56 | Colorectal cancer_Homo sapiens_hsa05210 | 0.95154784 |
57 | Spliceosome_Homo sapiens_hsa03040 | 0.94749546 |
58 | Legionellosis_Homo sapiens_hsa05134 | 0.93115043 |
59 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.91586822 |
60 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.90972336 |
61 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.90199135 |
62 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.88767678 |
63 | Thyroid cancer_Homo sapiens_hsa05216 | 0.87959702 |
64 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.85971070 |
65 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.84968292 |
66 | Pertussis_Homo sapiens_hsa05133 | 0.82869830 |
67 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.82716906 |
68 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.81991595 |
69 | RNA transport_Homo sapiens_hsa03013 | 0.81956963 |
70 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.81530294 |
71 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.81458009 |
72 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.80496942 |
73 | Lysine degradation_Homo sapiens_hsa00310 | 0.78641477 |
74 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.78378844 |
75 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.77652789 |
76 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.77452210 |
77 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.77254985 |
78 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.76403002 |
79 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.74514475 |
80 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.74242749 |
81 | Hepatitis C_Homo sapiens_hsa05160 | 0.74088279 |
82 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.73801538 |
83 | Sulfur relay system_Homo sapiens_hsa04122 | 0.72577777 |
84 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.71548900 |
85 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.70214932 |
86 | Lysosome_Homo sapiens_hsa04142 | 0.69956974 |
87 | Endocytosis_Homo sapiens_hsa04144 | 0.68108745 |
88 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.67351842 |
89 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.66436654 |
90 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.65194281 |
91 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.64362733 |
92 | Galactose metabolism_Homo sapiens_hsa00052 | 0.64060651 |
93 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.63640205 |
94 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.63158813 |
95 | Malaria_Homo sapiens_hsa05144 | 0.62883489 |
96 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.62362701 |
97 | Bladder cancer_Homo sapiens_hsa05219 | 0.61973351 |
98 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.61758772 |
99 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.61670505 |
100 | Homologous recombination_Homo sapiens_hsa03440 | 0.58913248 |
101 | Insulin resistance_Homo sapiens_hsa04931 | 0.58414923 |
102 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.57006205 |
103 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.56260634 |
104 | Prostate cancer_Homo sapiens_hsa05215 | 0.55545200 |
105 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.54460752 |
106 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.54092334 |
107 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.54001203 |
108 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.52742726 |
109 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.52291692 |
110 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.51914805 |
111 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.51537109 |
112 | Glioma_Homo sapiens_hsa05214 | 0.50008697 |
113 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.49295720 |
114 | Allograft rejection_Homo sapiens_hsa05330 | 0.49083670 |
115 | Endometrial cancer_Homo sapiens_hsa05213 | 0.49073775 |
116 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.48377323 |
117 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.48256659 |
118 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.47541994 |
119 | Pathways in cancer_Homo sapiens_hsa05200 | 0.47419059 |
120 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.47323683 |
121 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.43550457 |
122 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.43037254 |
123 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.42533005 |
124 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.42082065 |
125 | Salmonella infection_Homo sapiens_hsa05132 | 0.41570064 |
126 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.41164309 |
127 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.40935462 |
128 | RNA degradation_Homo sapiens_hsa03018 | 0.40895918 |
129 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.39904033 |
130 | Prion diseases_Homo sapiens_hsa05020 | 0.38963759 |
131 | * Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.36673369 |
132 | Amoebiasis_Homo sapiens_hsa05146 | 0.35746159 |
133 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.35545752 |